Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (HKG: 1349)

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 15, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	7,410	8,057	7,767	13,434	15,730	4,117
Market Cap Growth	-17.04%	3.73%	-42.18%	-14.60%	282.12%	14.07%
Enterprise Value	6,273	6,850	6,427	12,106	14,244	3,733
Last Close Price	2.64	2.41	3.19	3.45	3.38	3.89
PE Ratio	24.82	67.32	49.79	51.31	80.44	16.19
Forward PE	-	22.46	22.46	22.46	22.46	22.46
PS Ratio	3.78	8.60	6.66	9.60	15.89	3.58
PB Ratio	1.05	3.10	3.05	5.00	6.59	3.94
P/TBV Ratio	2.87	3.22	3.13	5.20	6.78	4.22
P/FCF Ratio	-	-	88.13	73.56	187.64	16.08
P/OCF Ratio	715.26	102.98	41.57	40.70	117.21	13.67
PEG Ratio	0.69	0.69	0.69	0.69	0.69	0.69
EV/Sales Ratio	8.19	7.31	5.51	8.65	14.38	3.24
EV/EBITDA Ratio	70.72	50.62	30.41	45.55	62.59	11.83
EV/EBIT Ratio	121.25	80.59	49.83	60.61	84.03	14.45
EV/FCF Ratio	-278.08	-	72.92	66.29	169.90	14.58
Debt / Equity Ratio	0.00	0.01	0.06	0.01	0.01	0.17
Debt / EBITDA Ratio	0.14	0.13	0.64	0.14	0.10	0.54
Debt / FCF Ratio	-	-	1.60	0.21	0.28	0.68
Asset Turnover	0.25	0.29	0.36	0.43	0.41	0.68
Inventory Turnover	1.45	1.76	2.27	2.26	1.95	2.41
Quick Ratio	5.89	3.60	2.98	3.56	4.63	1.90
Current Ratio	6.23	3.70	3.07	3.65	4.74	1.99
Return on Equity (ROE)	4.47%	4.70%	6.18%	10.12%	11.17%	23.38%
Return on Assets (ROA)	1.05%	1.65%	2.48%	3.85%	4.39%	9.52%
Return on Capital (ROIC)	1.21%	2.03%	3.10%	4.79%	5.73%	13.17%
Earnings Yield	1.61%	1.49%	2.01%	1.95%	1.24%	6.18%
FCF Yield	-0.31%	-0.38%	1.13%	1.36%	0.53%	6.22%
Dividend Yield	1.59%	3.20%	2.48%	2.49%	1.76%	2.01%
Payout Ratio	88.08%	70.10%	51.48%	24.45%	42.37%	30.88%
Buyback Yield / Dilution	-0.54%	-0.28%	1.30%	-5.59%	-7.20%	-
Total Shareholder Return	1.05%	2.91%	3.78%	-3.11%	-5.44%	2.01%

Source: S&P Capital IQ. Standard template. Financial Sources.